USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K

MARCO ANTONIO CALZADO CANALE2026-01-292026-01-29202210.1002/1878-0261.132172-s2.0-85129155459https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/34871Cancer ResearchGeneticsMolecular MedicineOncologyUSP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3Kresearch article